Q2 2022 EBITDA $31 Million before hedge losses and before capex to grow production.
- Forums
- ASX - By Stock
- Ann: Successful Montney Re-testing Program Supports Next Stage
Q2 2022 EBITDA $31 Million before hedge losses and before capex...
Featured News
Add CE1 (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.004(66.7%) |
Mkt cap ! $6.334M |
Open | High | Low | Value | Volume |
0.7¢ | 1.0¢ | 0.7¢ | $247.9K | 33.21M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 555555 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1070684 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1344900 | 0.010 |
2 | 655000 | 0.009 |
8 | 7226737 | 0.008 |
6 | 5798571 | 0.007 |
9 | 24468617 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1245245 | 3 |
0.010 | 791181 | 6 |
0.011 | 1090600 | 5 |
0.012 | 3702731 | 3 |
0.015 | 262857 | 2 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
CE1 (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online